TickerFacts.

Company research / STAA

Staar Surgical Co (STAA)

Build a valuation ↗↓ Download CSV

SEC name STAAR SURGICAL CO · CIK 0000718937 · Nasdaq · Ophthalmic Goods

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends around Jan 2

For the year ended 2026-01-02 (fiscal 2025), Staar Surgical Co reported revenue of $239.44M. Revenue fell 23.7% from the prior annual period. Over the twelve months to 2026-07-03, revenue was $339.59M.

Key ratios (year ended 2026-01-02, fiscal 2025)

76.2%
Gross margin
-38.3%
Operating margin
-33.6%
Net margin
-23.4%
Return on year-end equity
-23.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K/A (current report) · 2026-10-05

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-07-03 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-07-03		2026-01-02, Fiscal 20252024-12-272023-12-292022-12-302021-12-312021-01-01, Fiscal 20202020-01-03, Fiscal 20192018-12-282017-12-292016-12-30
Revenue$339.59M$239.44M$313.90M$322.42M$239.44M$230.47M$163.46M$150.19M$123.95M$90.61M$82.43M
Cost of Revenue$79.39M$57.02M$74.32M$69.76M$61.01M$51.84M$45.10M$38.23M$32.44M$26.33M$24.06M
Gross Profit$260.20M$182.42M$239.58M$252.65M$223.38M$178.64M$118.36M$111.95M$91.51M$64.28M$58.37M
R&D Expense$38.32M$40.05M$45.32M$40.48M$35.98M$33.86M$31.92M$25.30M$22.03M$20.04M$20.67M
Operating Income$13.73M-$91.71M-$12.61M$28.10M$43.80M$33.34M$6.77M$11.85M$6.59M-$3.63M-$12.65M
Net Income$3.84M-$80.45M-$20.21M$21.35M$39.66M$27.51M$5.91M$14.05M$4.97M-$2.14M-$12.13M
EPS (Diluted)n/a-$1.62-$0.41$0.43$0.80$0.56$0.12$0.30$0.11-$0.05-$0.30
Total Assets$475.20M$451.68M$509.52M$488.69M$418.82M$345.78M$257.42M$207.52M$167.34M$67.93M$65.48M
Total Liabilities$109.81M$107.49M$112.19M$102.74M$82.71M$87.22M$60.19M$47.64M$34.91M$25.00M$27.57M
Shareholders' Equity$365.40M$344.18M$397.33M$385.95M$336.11M$261.57M$197.22M$159.88M$132.43M$42.94M$37.91M
Cash & Equivalents$148.58M$153.15M$144.16M$183.04M$86.48M$199.71M$152.45M$119.97M$103.88M$18.52M$14.00M
Operating Cash Flow-$3.25M-$34.23M$15.72M$14.59M$35.72M$43.96M$20.95M$25.80M$12.77M$2.85M$1.05M
Capital Expenditures$3.50M$5.82M$23.39M$18.19M$18.11M$13.64M$8.40M$10.10M$2.25M$1.05M$3.21M
Free Cash Flow-$6.75M-$40.05M-$7.67M-$3.59M$17.61M$30.32M$12.55M$15.70M$10.52M$1.81M-$2.16M
Share Repurchasesn/a$6.46Mn/an/an/an/an/an/an/an/an/a
Shares Outstanding50.12M49.40M49.29M48.84M48.21M47.72M46.49M44.82M44.20M41.38Mn/a
Weighted Average Diluted Sharesn/a49.57M49.12M49.43M49.38M49.46M47.95M46.90M45.26M41.00M40.33M
EPS (Basic)n/a-$1.62-$0.41$0.44$0.83$0.58$0.13$0.32$0.12-$0.05-$0.30

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView